Clinical Study of Allergic Rhinitis Therapy by Stem Cells

Summary

The investigators is now carrying out a clinical study of Umbilical cord Mesenchymal Stem Cells (UCMSCs) in the treatment of Allergic rhinitis (AR). UCMSCs is known to its multilineage differentiation potential, strong proliferation ability, low immunogenicity, convenient material acquisition, and fewer restrictions on ethical and moral issues. The investigators hope to find a novel, minimally invasive, effective and simple treatment for the large number of patients with persistent moderate to severe AR.

Timeline

Start

2022-06-13

Primary completion

2024-12-15

Completion

2024-12-15

Drugs

Indications